Search Results 1071-1080 of 18419 for Obesity/Overweight Treatment
Obesity (BMI ≥ 30 kg/m^2);; Type 2 diabetes diagnosed per 2013 American Diabetes Association criteria (hemoglobin A1c [HbA1c] ≥ 6.5%, fasting plasma ...
Learn how a diagnosis of atypical lobular hyperplasia or atypical ductal hyperplasia affects your risk of breast cancer and what you can do.
The purpose of this study is to investigate the effectiveness and safety of three dose levels of subcutaneous semaglutide for the treatment of patients who have ...
A Pilot Study to Assess the Efficacy of Rituximab Therapy in Treatment Resistant FSGS ... BMI ≥35) ... obesity, vesicoureteral reflux, or renal mass reduction) ...
The purpose of this study is to determine the safety and practical treatment use of STEM cells collected from a patient's own fat tissue, expanded in laboratory ...
Even with aggressive treatment ... And it's usually not what's behind being overweight or obese. ... Treatment with these drugs should begin one to two weeks before ...
The Atkins Diet notes that obesity and related health problems, such as type 2 diabetes and heart disease, are the fault of the typical low-fat, high-carb ...
Altered NAD+ metabolism is linked to high-fat diets and multiple sclerosis. Mayo Clinic found that normalizing levels of that enzyme promotes re-myelination ...
And so we think this is a very exciting treatment option for very selected patients in order to try to cure them of their colorectal liver metastases.
The purpose of this study is to continue to provide olaratumab to eligible patients who are currently receiving olaratumab commercially for the treatment of ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!